Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hypogonadism × Pioglitazone × Clear all

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 8 Insulin Resistance 7 Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4 Diabetes Mellitus, Type 2 4 Prostatic Neoplasms 3 Pancreatic Neoplasms 3 Urinary Bladder Neoplasms 2 Metabolic Syndrome 2 Leukoplakia, Oral 2 Leukemia, Myeloid, Chronic-Phase 2 Inflammation 2 Diabetes Mellitus 2 Carotid Intimal Medial Thickness 1 2 Carcinoma, Non-Small-Cell Lung 2 Breast Neoplasms 2 Sleep Apnea, Obstructive 1 Skin Neoplasms 1 Recurrence 1 Prostatic Neoplasms, Castration-Resistant 1 Pharmacokinetics of MDV3100 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Meningioma 1 Memory Disorders 1 Lung Neoplasms 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Hypogonadism 1 Hyperinsulinism 1

Interventions

testosterone undecanoate 3 Testosterone 3 Alendronate 2 testosterone 17 beta-cypionate 1 Triptorelin Pamoate 1 Testosterone Propionate 1 Surveys and Questionnaires 1 Standard of Care 1 Specimen Handling 1 Practice Guidelines as Topic 1 Pioglitazone 1 Orchiectomy 1 Observation 1 Methyltestosterone 1 Mental Status and Dementia Tests 1 Gels 1 Drug Evaluation 1 Clomiphene 1 Castor Oil 1 Blood Specimen Collection 1 Anastrozole 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00743327 2012-08-06

ADT

National Institutes of Health Clinical Center (CC)

Diabetes Mellitus, Hypogonadism, Inflammation, Metabolic Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡